Related Experiment Video
Updated: Jul 27, 2025
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Metastasis in neuroblastoma: the
1Pediatric Research Group, Department of Clinical Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway.
Abstract:
Oncogenic drivers like MYCN in neuroblastoma subsets continues to present a significant challenge owing to its strong correlation with high-risk metastatic disease and poor prognosis. However, only a limited number of MYCN-regulatory proteins associated with tumor initiation and progression have been elucidated. In this minireview, I summarize the recent progress in understanding the functional role of MYCN and its regulatory partners in neuroblastoma metastasis.
Insights
MYCN drives high-risk neuroblastoma metastasis, posing a significant challenge. This review highlights recent findings on MYCN and its partners in neuroblastoma tumor initiation and progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- MYCN is a key oncogenic driver in specific neuroblastoma subsets.
- MYCN amplification correlates strongly with high-risk metastatic disease and poor patient prognosis.
- Understanding MYCN's regulatory network is crucial for targeting neuroblastoma progression.
Purpose of the Study:
- To summarize recent advancements in understanding the functional role of MYCN.
- To elucidate the roles of MYCN-regulatory proteins in neuroblastoma initiation and progression.
- To provide insights into MYCN's involvement in neuroblastoma metastasis.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies investigating MYCN and its interacting proteins.
- Synthesis of current knowledge on MYCN's regulatory mechanisms in neuroblastoma.
Main Results:
- MYCN plays a critical role in neuroblastoma tumor initiation and progression.
- Several MYCN-regulatory proteins have been identified, influencing metastasis.
- The functional interplay between MYCN and its partners is key to understanding metastatic potential.
Conclusions:
- Targeting MYCN and its regulatory network offers potential therapeutic strategies for high-risk neuroblastoma.
- Further research into MYCN's regulatory partners is essential for developing effective treatments.
- Elucidating these mechanisms can improve outcomes for patients with metastatic neuroblastoma.
